TMDX Filing
10-QFiling Date: Aug 4, 2026

TransMedics Group, Inc. (TMDX) · Quarterly Report (10-Q) SEC Filing

10-Q

descriptionView SEC Filing
ACC: 0001193125-26-332843open_in_new
Key Financial MetricsFY2026 · 2026-06-30
Revenue$189.9M
Net Income$14.7M
Total Assets$1.46B
Stockholders' Equity$518.1M
Operating Cash Flow$41.8M

keid analysis is for reference only and does not constitute investment advice.